Houston, TX - February 3, 2012 - Genentech announced that Erivedge ™ (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with basal cell carcinoma (BCC, a type of skin cancer.) Erivedge™ was approved on January 30, 2012. Dr. Leonard H. Goldberg, a Houston Dermatological surgeon, has …Read More
7515 South Main Street, Suite 240
Houston, TX 77030
Phone: (713) 791-9966
Monday–Friday: 8 a.m.–5 p.m.
Friday: 8 a.m.–4 p.m.
Monthly Archives: February 2012
New treatments have been approved for for both actinic keratoses and basal cell carcinoma. From Skin and Allergy News: Actinic Keratoses "The Food and Drug Administration approved two strengths of ingenol mebutate gel for the treatment of actinic keratoses Jan. 23. The 0.015% formulation of ingenol mebutate gel (Picato) was approved for the treatment of …Read More